BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35044972)

  • 1. Mediators of the Effect of Corneal Cross-Linking on Visual Acuity for Fungal Ulcers: A Prespecified Secondary Analysis From the Cross-Linking-Assisted Infection Reduction Trial.
    Prajna NV; Radhakrishnan N; Lalitha P; Liu Z; Keenan JD; Arnold BF; Rose-Nussbaumer J
    Cornea; 2022 Oct; 41(10):1217-1221. PubMed ID: 35044972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-Linking-Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis.
    Prajna NV; Radhakrishnan N; Lalitha P; Austin A; Ray KJ; Keenan JD; Porco TC; Lietman TM; Rose-Nussbaumer J
    Ophthalmology; 2020 Feb; 127(2):159-166. PubMed ID: 31619359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Postfungal Keratitis Corneal Scar Features With Visual Acuity.
    Menda SA; Das M; Panigrahi A; Prajna NV; Acharya NR; Lietman TM; McLeod SD; Keenan JD
    JAMA Ophthalmol; 2020 Feb; 138(2):113-118. PubMed ID: 31804657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
    Prajna NV; Mascarenhas J; Krishnan T; Reddy PR; Prajna L; Srinivasan M; Vaitilingam CM; Hong KC; Lee SM; McLeod SD; Zegans ME; Porco TC; Lietman TM; Acharya NR
    Arch Ophthalmol; 2010 Jun; 128(6):672-8. PubMed ID: 20547942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-Linking Assisted Infection Reduction (CLAIR): A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Bacterial Keratitis.
    Prajna NV; Radhakrishnan N; Lalitha P; Rajaraman R; Narayana S; Austin AF; Liu Z; Keenan JD; Porco TC; Lietman TM; Rose-Nussbaumer J
    Cornea; 2021 Jul; 40(7):837-841. PubMed ID: 33079921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
    Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Devi L; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2017 Jun; 135(6):520-525. PubMed ID: 28426856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.
    Hoffman JJ; Yadav R; Sanyam SD; Chaudhary P; Roshan A; Singh SK; Singh SK; Mishra SK; Arunga S; Hu VH; Macleod D; Leck A; Burton MJ
    Ophthalmology; 2022 May; 129(5):530-541. PubMed ID: 34896126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Value of Persistent Culture Positivity in Fungal Keratitis in the Mycotic Antimicrobial Localized Injection Trial.
    Pickel J; Narayana S; Krishnan T; Ramakrishnan S; Samantaray PP; Porco TC; Redd T; Lietman TM; Rose-Nussbaumer J
    Am J Ophthalmol; 2020 Jul; 215():1-7. PubMed ID: 32171765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
    Sun CQ; Lalitha P; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Oldenburg CE; Ray KJ; McLeod SD; Acharya NR; Lietman TM;
    Ophthalmology; 2014 Aug; 121(8):1495-500.e1. PubMed ID: 24746358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phakic intraocular lenses for the treatment of refractive errors: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(14):1-120. PubMed ID: 23074518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pretreatment with antifungal agents on clinical outcomes in fungal keratitis.
    Sun CQ; Prajna NV; Krishnan T; Rajaraman R; Srinivasan M; Raghavan A; O'Brien KS; McLeod SD; Acharya NR; Rose-Nussbaumer J;
    Clin Exp Ophthalmol; 2016 Dec; 44(9):763-767. PubMed ID: 27329780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of corneal irregularity and scarring after infectious keratitis using anterior segment optical coherence tomography.
    Ichikawa K; Ono T; Chen L; Kitamoto K; Taketatni Y; Toyono T; Yoshida J; Aihara M; Miyai T
    Graefes Arch Clin Exp Ophthalmol; 2024 Jan; 262(1):133-141. PubMed ID: 37470808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT).
    Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; Glidden DV; Ray KJ; Hong KC; Oldenburg CE; Lee SM; Zegans ME; McLeod SD; Lietman TM; Acharya NR;
    Arch Ophthalmol; 2012 Feb; 130(2):143-50. PubMed ID: 21987582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.
    Prajna NV; Krishnan T; Rajaraman R; Patel S; Srinivasan M; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Porco TC; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    JAMA Ophthalmol; 2016 Dec; 134(12):1365-1372. PubMed ID: 27787540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.
    Rose-Nussbaumer J; Prajna NV; Krishnan KT; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; McLeod SD; Porco TC; Lietman TM; Acharya NR; Keenan JD;
    JAMA Ophthalmol; 2015 Jun; 133(6):642-6. PubMed ID: 25764482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Utility of Repeat Culture in Fungal Corneal Ulcer Management: A Secondary Analysis of the MUTT-I Randomized Clinical Trial.
    Ray KJ; Lalitha P; Prajna NV; Rajaraman R; Krishnan T; Srinivasan M; Ryg P; McLeod S; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    Am J Ophthalmol; 2017 Jun; 178():157-162. PubMed ID: 28385473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of Density, Depth, and Surface Irregularity of Superficial Corneal Opacification with Visual Acuity.
    Joshi VP; Chatterjee S; Basu S
    Curr Eye Res; 2023 Jun; 48(6):536-545. PubMed ID: 36724802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Significance of Repeat Cultures in the Treatment of Severe Fungal Keratitis.
    Ray KJ; Prajna NV; Lalitha P; Rajaraman R; Krishnan T; Patel S; Das M; Shah R; Dhakhwa K; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
    Am J Ophthalmol; 2018 May; 189():41-46. PubMed ID: 29438654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Corneal Cross-linking versus Standard Care on Keratoconus Progression in Young Patients: The KERALINK Randomized Controlled Trial.
    Larkin DFP; Chowdhury K; Burr JM; Raynor M; Edwards M; Tuft SJ; Bunce C; Caverly E; Doré C;
    Ophthalmology; 2021 Nov; 128(11):1516-1526. PubMed ID: 33892046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, randomized contralateral eye study of accelerated and conventional corneal cross-linking in pediatric keratoconus.
    Eissa SA; Yassin A
    Int Ophthalmol; 2019 May; 39(5):971-979. PubMed ID: 29564806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.